The ANZCHOG Office is a small team who work closely with our extensive multi-disciplinary membership and international colleagues. We are passionate about our work and are dedicated to making a difference for children experiencing cancer.
Robyn Strong
Chief Executive Officer
Robyn works closely with the ANZCHOG Board, developing and operationalising ANZCHOG's strategic plan. Robyn provides oversight to all of ANZCHOG's office activities and is responsible for establishing and maintaining relationships with ANZCHOG's national and international partners and supporters. She provides overarching management of ANZCHOG-sponsored trial activity.
Dr Janelle Jones
Business & Grants Manager
Janelle manages ANZCHOG's research programs, coordinating project development, national collaborations and securing research funding. She also undertakes policy development and provides extensive grant management support. Janelle is also responsible for ANZCHOG’s communications and is the staff liaison for ANZCHOG's Annual Scientific Meeting.
Michelle Carr
National Trials Manager
Michelle provides high level quality oversight of ANZCHOG sponsored clinical trials. She provides trial management support, review and development of trial quality management plans, and implements ANZCHOG quality processes and activities.
Dr Kathryn Kinross
National Study Coordinator
Kathryn is the national study coordinator for the AIM BRAIN Project, MNP2.0 trials and the ReRAD trial. She provides support to ANZCHOG investigators in the development of new ANZCHOG clinical trial protocols. Additionally, she coordinates ANZCHOG projects such as the National Minimum Dataset project and the clinical trial registry.
Rosie Newman
National Study Coordinator
Rosie is responsible for the central coordination and conduct of four ANZCHOG-sponsored trials, the PARC study and the SJ-ELiOT, COZMOS and PNOC019 trials. She is the central point of contact for all participating centres and will liaise closely with the international sponsors and Australian regulatory bodies to ensure all trial requirements are met.
Matthew Ivers
National Study Coordinator
Matt is responsible for the central coordination and conduct of two ANZCHOG-sponsored trials, FaR-RMS and TiNT. He is the central point of contact for all participating centres and will liaise closely with the international sponsors and Australian regulatory bodies to ensure all trial requirements are met.
Kim Wright
National Study Coordinator
Kim is responsible for the central coordination and conduct of two ANZCHOG-sponsored trials, MetMED and CONNECT1903. She is the central point of contact for all participating centres and will liaise closely with the international sponsors and Australian regulatory bodies to ensure all trial requirements are met.
Annette Dempsey
National Study Coordinator
Annette is responsible for the central coordination and conduct of one ANZCHOG-sponsored trials, MyeChild. She is the central point of contact for all participating centres and will liaise closely with the international sponsors and Australian regulatory bodies to ensure all trial requirements are met.
Sharina Omerovic
Clinical Trial Start-Up Specialist
Sharina is involved in the national start-up of ANZCHOG-sponsored trials, specifically the preparation and coordination of submissions to ethics, regulatory, and other bodies. Sharina assists with the early development and planning activities, reviews feasibility analyses, and provides input into logistics and operational planning.
Kylie May
Project & Grants Officer
Kylie assists in the management of ANZCHOG’s research grants portfolio. She is also responsible for establishment and administration of the ANZCHOG digital platform (eCommunity) for members.
Sara Field
Administration & Finance Officer
Sara acts as the main point of contact for the ANZCHOG office and is responsible for general administration and finance. She is also responsible for membership queries and will assist in grant management.
Angel Marazita
Clinical Trial Assistant
Catherine is responsible for providing support to ANZCHOG trial sites through management of clinical trial documentation. She manages the ANZCHOG Tumour Board and relapsed screening logs.